Liver cirrhosis and encephalopathy: Clinical and metabolic consequences and nutritional support;Cirrosis y encefalopatía hepáticas: Consecuencias clínico-metabólicas y soporte nutricional

Nutricion Hospitalaria

Volumn 23, Issue SUPPL. 2, 2008, Pages 8-18

  Mesejo, A ^a   Juan, M ^a   Serrano, A ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Cirrhosis; Hepatic encephalopathy; Malnourishement; Nutrition

Indexed keywords

AMINO ACID METABOLISM; CARBOHYDRATE METABOLISM; CATABOLISM; DISEASE ASSOCIATION; DISEASE SEVERITY; ENTERIC FEEDING; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; HUMAN; LIPID STORAGE; LIVER CIRRHOSIS; LIVER FAILURE; METABOLIC DISORDER; MORTALITY; NUTRITIONAL SUPPORT; PROGNOSIS; PROTEIN RESTRICTION; QUALITY OF LIFE; REVIEW; SURVIVAL; SYMPTOM;

ALGORITHMS; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PROTEIN-ENERGY MALNUTRITION;

EID: 46749102194     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Esteller Pérez A, González Gallego J. Nutrición en las enfermedades hepatobiliares. En: Gil A Ed. Tratado de nutrición. Tomo IV. Acción Médica, Madrid, 2005, pp. 907-57.
2. Caregaro L, Alberino F, Samodio P y cols. Malnutrition in alcoholic and virus-related cirrosis. Am J Clin Nutr 1996; 63:602-609.
3. Marsano L, Martin A, Randall H. Current nutrition in liver disease. Curr Opin Gastroenterol 2002; 18:246-253.
4. McCullough AJ, Tavill AS. Disordered energy and protein metabolism in liver disease. Semin Liver Dis 1991; 11:265-277.
5. Madden AM, Bradbury W, Morgan MY. Taste perception in cirrhosis: its relationship to circulating micronutrients and food preferences. Hepatology 1997; 26:40-48.
6. Quigley EM. Gastrointestinal dysfunction in liver disease and portal hypertension. Gut-liver interaction revisited. Dig Dis Sci 1996; 41:557-561.
7. Thompson GR. Actions of neomycin on the intraluminal phase of lipid absorption. J Clin Invest 1971; 50:321-323.
8. Muller MJ. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 1992; 15:782-794.
9. Selberg O, Bottcher J, Tusch G y cols. Identification of high and low risk patients before liver transplantation. A prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 1997; 25:652-657.
10. Merli M, Riggio O, Dally L. Does malnutrition affect survival in cirrhosis? Hepatology 1996; 23:1041-1046.
11. Pirlich M, Seiberg O, Boker K y cols. The creatinine approach to estimate skeletal muscle mass in patients with cirrhosis. Hepatology 1996; 24:1422-1427.
12. Pirlich M, Schutz T, Spachos T y cols. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology 2000; 32:1208-1215.
13. Merli M, Riggio O, Romiti A y cols. Basal energy production rate and substrate use in stable cirrhotic patients. Hepatology 1990; 12:106-112.
14. Campillo B, Bories P, Pornin B y cols. Influence of liver failure, ascites and energy expenditure on the response to oral nutrition in alcoholic liver cirrhosis. Nutrition 1997; 13:613-621.
15. Petrides AS. Liver disease and diabetes mellitus. Diabetes Rev 1994; 2:2-18.
16. Mullen KD, Webwe FL. Role of malnutrition in hepatic encephalopathy. Semin Liver Dis 1991; 11:292-304.
17. Khoruts A, Stahnke L, McClain CJ y cols. Circulating tumor necrosis factor. Interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991; 13:267-276.
18. Guarner C, Soriano G, Tomas A y cols. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993; 18:1139-1143.
19. Jiménez Jiménez FJ, Montejo González JC, Núñez Ruiz R. Nutrición artificial en la insuficiencia hepática. Nutr Hosp 2005; 20(Supl. 2):22-24.
20. Wright G, Jalan R. Management of hepatic encephalopathy in patients with cirrosis. Best Pract Res Clin Gastroenterol 2007; 21:95-110.
21. Norenberg MD. Astrocytic-ammonia interactions in hepatic encephalopathy. Semin Liver Dis 1996; 16:245-253.
22. Arias JL, Aller MA, Sánchez F y cols. The inflammatory bases of hepatic encephalopathy. Eur J Gastroenterol Hepatol 2006; 18:1297-1310.
23. Kramer L, Tribl B, Gebdo A y cols. Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology 2000; 31:30-34.
24. Donovan JP, Schafer DF, Shaw BW y cols. Cerebral oedema and increased intracranial pressure in chronic liver disease. Lancet 1998; 351:719-721.
25. Blei A, Córdoba J. Hepatic encephalopathy. Am J Gastroenterol 2001; 96:1968-1976.
26. Cabré E, González-Huix F, Abad A y cols. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized trial. Gastroenterology 1990; 98:715-720.
27. Marchesini G, Dioguardi FS, Bianchi GP. Long-term oral branched chain aminoacid treatment in chronic hepatic encephalopathy. J Hepatol 1990; 11:92-101.
28. Mendenhall CL, Roselle GA, Gartside P y cols. Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration cooperative studies. Alcohol Clin Exp Res 1995; 19:635-641.
29. Cabré E, Rodríguez-Iglesias P, Caballería J y cols. Short and long term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology 2000; 32:36-42.
30. Plauth M, Cabré E, Riggio O y cols. ESPEN Guidelines on enteral nutrition: liver disease. Clin Nutr 2006; 25:285-294.
31. Bran OS. Infectious complications of cirrhosis. Curr Gastroenterol Rep 2001; 4:285-292.
32. McCullough AJ. Malnutrition in liver disease. Liver Transplant 2000; 6(Supl. 1):85-96.
33. ASPEN Board of Directors. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. Liver disease. J Parent Enteral Nutr 2002; 26(Supl.1):65-67.
34. Córdoba J, López-Hellín J, Planas M y cols. Normal protein for episodic hepatic encephalopathy: results of a randomized trial. J Hepatol 2004; 41:38-43.
35. Fabbri A, Magrini N, Bianchi G y cols. Overview of randomized clinical trials of oral branched chain amino acid treatment in chronic hepatic encephalopathy. J Parent Enteral Nutr 1996; 20:159-164.
36. Marchesini G, Bianchi G, Merli M y cols. The Italian BCAA Study Group. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 2003; 124:1792-1801.
37. Muto Y, Sato S, Watanabe A, for the LOTUS group y cols. Effects of oral branched chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005; 3:705-713.
38. Naylor CD, O'Rourke K, Detsky AS y cols. Parenteral nutrition with branched chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology 1989; 97:1003-1042.
39. Bianchi GP, Marchesini G, Fabbri A y cols. Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized crossover comparison. J Intern Med 1993; 233:385-392.
40. Chang WK, Chao YC, Tang HS y cols. Effects of extra carbohydrate supplementation in the late evening on energy expenditure and substrate oxidation in patients with liver cirrhosis. J Parent Enteral Nutr 1997; 21:96-99.
41. Rubio C, González D, Martín-Izquierdo RE y cols. El zinc: oligoelemento esencial. Nutr Hosp 2007; 101-107.
42. Marchesini G, Fabbri A, Bianchi GP y cols. Zinc supplementation and amino acid nitrogen matabolism in patients with advanced cirrhosis. Hepatology 1996; 23:1084-1092.